BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 31059567)

  • 21. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma.
    Li Z; Li F; Peng Y; Fang J; Zhou J
    Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seven-senescence-associated gene signature predicts overall survival for Asian patients with hepatocellular carcinoma.
    Xiang XH; Yang L; Zhang X; Ma XH; Miao RC; Gu JX; Fu YN; Yao Q; Zhang JY; Liu C; Lin T; Qu K
    World J Gastroenterol; 2019 Apr; 25(14):1715-1728. PubMed ID: 31011256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma.
    He D; Liao S; Cai L; Huang W; Xie X; You M
    BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M; Sun S; Zhao R; Guan R; Zhang Z; Li S; Wei W; Guo R
    Mol Med; 2022 Feb; 28(1):16. PubMed ID: 35123387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A six-gene-based prognostic signature for hepatocellular carcinoma overall survival prediction.
    Wang Z; Teng D; Li Y; Hu Z; Liu L; Zheng H
    Life Sci; 2018 Jun; 203():83-91. PubMed ID: 29678742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
    Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
    BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus‑associated hepatocellular carcinoma.
    Wang X; Huang K; Zeng X; Liu Z; Liao X; Yang C; Yu T; Han C; Zhu G; Qin W; Peng T
    Oncol Rep; 2019 May; 41(5):2855-2875. PubMed ID: 30896816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment.
    Zhang L; Wang Y; Li X; Wang Y; Wu K; Wu J; Liu Y
    Front Endocrinol (Lausanne); 2020; 11():467. PubMed ID: 32793117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
    Chen S
    DNA Cell Biol; 2021 Feb; 40(2):359-372. PubMed ID: 33290144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics.
    Shen J; He L; Li C; Wen T; Chen W; Lu C; Yan L; Li B; Yang J
    Oncotarget; 2016 Dec; 7(49):80783-80793. PubMed ID: 27811374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.
    Huang G; Wang C; Fu X
    Future Oncol; 2021 Nov; 17(33):4481-4495. PubMed ID: 34374301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma.
    Zhang L; Li Y; Dai Y; Wang D; Wang X; Cao Y; Liu W; Tao Z
    Sci Rep; 2021 Sep; 11(1):18875. PubMed ID: 34556750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.
    Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
    Cancer Sci; 2019 Sep; 110(9):2905-2923. PubMed ID: 31335995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients.
    Bai Z; Li H; Li C; Sheng C; Zhao X
    Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.